TCL Archive DeVita On Problems Of Drug Response: There May be Tw Populations Of Cells; Molecular Medicine will Change Treatment December 13, 1991
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials April 5, 1974